Annual report of the Australian Meningococcal Surveillance Programme 1998
DOI:
https://doi.org/10.33321/cdi.1999.23.42Keywords:
disease surveillance, meningococcal disease, Neisseria meningitidisAbstract
The National Neisseria Network has undertaken meningococcal isolate surveillance by means of a collaborative laboratory-based initiative since 1994. The phenotype (serogroup, serotype and serosubtype) and antibiotic susceptibility of 323 isolates of Neisseria meningitidis from invasive cases of meningococcal disease were determined in 1998. Ninety per cent of the invasive isolates were either serogroup B or C. Serogroup B strains predominated in all States and Territories and were isolated from sporadic cases of invasive disease. Serogroup B phenotypes were diverse. Serogroup C isolates were most prominent in New South Wales, especially in adolescents and young adults. C:2a:P1.5 was the most frequently encountered phenotype and C:2b:P1.5,2 strains were also distributed widely. About three-quarters of all isolates showed decreased susceptibility to the penicillin group of antibiotics (MIC 0.06 to 0.5 mg/L). Four isolates showed reduced susceptibility to rifampicin, one to ciprofloxacin and one to chloramphenicol. Commun Dis Intell 1999;23:317-323.
Downloads
References
Maiden MCJ, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998;95:3140-3145.
Munro R, Tapsall J. Meningococcal disease in Australia. Commun Dis Intell 1996;20:368-371.
National Neisseria Network. Meningococcal Isolate Surveillance Australia 1994. Commun Dis Intell 1995:19:286-289.
National Neisseria Network. Meningococcal Isolate Surveillance Australia 1995. Commun Dis Intell 1996;20:422-424.
The Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme 1996. Commun Dis Intell 1997;21:217-221.
Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme. Commun Dis Intell 1998;22:205-211.
Australian Gonococcal Surveillance Programme. Penicillin sensitivity of gonococci in Australia: development of an Australian gonococcal surveillance programme. Br J Vener Dis 1984;60:226-230.
Ashton FE, Ryan JA, Borcyzk DA, Caugant DA, Mancino L, Huang D. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease. Canada J Clin Microbiol 1991;29:2489-2943.
Maiden MCJ, Spratt BG. Meningococcal conjugate vaccines: new opportunities and new challenges. Lancet 1999:354:615-616.
CDC. Serogroup Y meningococcal disease - Illinois, Connecticut, and selected areas, United States, 1989-1996. MMWR 1996;45:1010-1013.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 1999 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
